Eclipse Regenesis
CA - Mountain ViewBiotechnology
Focus: Eclipse Regenesis is a early-stage biotechnology company developing a tissue-growing device for short bowel syndrome, a rare and serious gastrointestinal disorder. The company is based in Mountain View, CA and operates at a pre-revenue or early clinical stage.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Eclipse Regenesis?
AI assessmentOnly pursue if you have high risk tolerance, are drawn to rare-disease innovation, and can afford extended pre-revenue uncertainty.
Why Work Here
- High-risk, high-reward opportunity in an underserved rare disease (short bowel syndrome) with limited treatment options and strong unmet medical need.
- Ground-floor role in a device-based therapeutic approach (distraction enterogenesis) that differentiates from traditional pharmaceutical pipelines.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Distraction Enterogenesis in Adult Patients with Short Bowel Syndrome
Short Bowel SyndromeOpen Jobs (1)
Help build intelligence for Eclipse Regenesis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.